Appendicitis
Immediate appendectomy, as opposed to interval
appendectomy, should be performed within 12 hours of decision to operate, except
in the case of an unstable/septic patient or the presence of free
perforation or generalized perforation, where surgery should be performed
emergently.
|
Simple appendicitis/unperforated appendicitis
|
Cefuroxime 1.5gm IV q8H
+
Metronidazole 500mg IV q8H
OR
Ampicillin/Sulbactam 1.5gm IV q6H
OR
Co-amoxiclav 1.2gm IV q8H
|
Penicillin allergy:
IV clindamycin 600-900mg
PLUS
IV gentamicin 5mg/kg
|
Treatment should be discontinued within 24 hours if no evidence of
perforation, abscess or local peritonitis.
|
Perforated appendix/ perforated viscus or
intestine/ Appendicular Mass
(palpable mass in the right lower
quadrant on physical examination or by a phlegmon (inflammatory mass) or
abscess on imaging studies)
|
Cefuroxime 1.5gm IV q8H
+
Metronidazole 500mg IV q8H
OR
Ampicillin/sulbactam 1.5-3.0gm IV q8H
OR
Co-amoxiclav 1.2gm IV
q8H
|
Cefoperazone 1-2gm IV q12H & Metronidazole
500mg IV q8H
|
Duration 4-7 days (if
adequate source control, no delay in surgical intervention and patient has
rapid clinical recovery)
|
Anal/ rectal abscess
|
|
Co-amoxiclav 1.2gm IV q8H
|
Cefuroxime 1.5gm IV q8H & Metronidazole
500mg IV q8H
|
Drainage is required
Duration 4-7 days (if adequate source control,
no delay in surgical intervention and patient has rapid clinical recovery)
|
Trauma
|
Abdominal trauma/ Stab wound/ suspected bowel
or solid organ injury
|
Common organisms:
Gram negative enteric aerobes and anaerobes
|
Co-amoxiclav 1.2gm IV q8H
|
Cefuroxime 1.5gm IV q8H & Metronidazole 500mg IV q8H
|
Duration 4-7 days (if adequate source control, no delay in surgical
intervention and patient has rapid clinical recovery)
|
Severe/infected wound:
Piperacillin/tazobactam 4.5gm IV q6H
|
Severe/infected wound:
Ciprofloxacin 400ng IV q12H & Clindamycin
600mg IV q8H
|
Vascular
|
Mycotic aneurysm & Vascular prosthesis
infection
|
|
Ceftriaxone 2gm IV q24H
|
Piperacillin/tazobactam 4.5gm IV q6H
|
Duration at least 6 weeks (IV then oral based on clinical response
and cultures)
Consider adding IV Vancomycin if suspecting MRSA/CoNS vascular
prosthesis infection.
|
Ischemic limb ulcers with infection
|
|
Ampicillin/sulbactam 1.5-3gm IV q6-8H for 7 days
|
Co-amoxiclav 1.2gm IV q8H for 7 days
|
May need longer duration if bone infection and debridement for adequate source control
|
Soft Tissue
|
Breast abscess/ Mastitis
|
Common organism: Staphylococcus aureus
High risk*
|
Co-amoxiclav 1.2gm IV q8H
OR
Ampicillin/Sulbactam 1.5gm IV q8H
|
Co-amoxiclav 625mg PO q8H
OR
Ampicillin/sulbactam 750mg PO q12H
|
*Patient with
1.
Uncontrolled DM
2.
immunosuppressive therapy
3.
Neutropenia
Drainage may be required for abscess
For lactating mastitis: consider sending
breastmilk for C+S if not responding after 48 hr of initial antibiotic
therapy or recurring mastitis.
Duration 10-14 days but may be shorter if
clinically responding.
|
Others
|
Cloxacillin 2gm IV q6H
OR
Cefazolin 1-2gm IV q8H
|
Cloxacillin 1gm PO q6H
OR
Cefalexin 500mg q6H
Penicillin allergy
Clindamycin 600mg IV/PO q8H
|